{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:58:46Z","timestamp":1790794726809,"version":"4.1.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T00:00:00Z","timestamp":1632096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003074","name":"Agencia Nacional de Promoci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003074","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Natural Killer (NK) cells play a key role in cancer immunosurveillance. However, NK cells from cancer patients display an altered phenotype and impaired effector functions. In addition, evidence of a regulatory role for NK cells is emerging in diverse models of viral infection, transplantation, and autoimmunity. Here, we analyzed clear cell renal cell carcinoma (ccRCC) datasets from The Cancer Genome Atlas (TCGA) and observed that a higher expression of NK cell signature genes is associated with reduced survival. Analysis of fresh tumor samples from ccRCC patients unraveled the presence of a high frequency of tumor-infiltrating PD-L1<jats:sup>+<\/jats:sup> NK cells,  suggesting that these NK cells might exhibit immunoregulatory functions. <jats:italic>In vitro<\/jats:italic>, PD-L1 expression was induced on NK cells from healthy donors (HD) upon direct tumor cell recognition through NKG2D and was further up-regulated by monocyte-derived IL-18. Moreover, <jats:italic>in vitro<\/jats:italic> generated PD-L1<jats:sup>hi<\/jats:sup> NK cells displayed an activated phenotype and enhanced effector functions compared to PD-L1<jats:sup>-<\/jats:sup> NK cells, but simultaneously, they directly inhibited CD8<jats:sup>+<\/jats:sup> T cell proliferation in a PD-L1-dependent manner. Our results suggest that tumors might drive the development of PD-L1-expressing NK cells that acquire immunoregulatory functions in humans. Hence, rational manipulation of these regulatory cells emerges as a possibility that may lead to improved anti-tumor immunity in cancer patients.<\/jats:p>","DOI":"10.3389\/fimmu.2021.745939","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T06:30:21Z","timestamp":1632119421000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":44,"title":["Tumor-Experienced Human NK Cells Express High Levels of PD-L1 and Inhibit CD8+ T Cell Proliferation"],"prefix":"10.3389","volume":"12","author":[{"given":"Jessica M.","family":"Sierra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florencia","family":"Secchiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sol Y.","family":"Nu\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximena L. Raffo","family":"Iraolagoitia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ziblat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n D.","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda V.","family":"Regge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Cecilia","family":"Santilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s I.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Gantov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldana","family":"Trotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Ameri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Vitagliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hernando R\u00edos","family":"Pita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Rico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Rovegno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina I.","family":"Domaica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norberto W.","family":"Zwirner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes B.","family":"Fuertes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,9,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.03.008","article-title":"The ILC World Revisited","volume":"46","author":"Diefenbach","year":"2017","journal-title":"Immunity"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nri2276","article-title":"Evolutionary Struggles Between NK Cells and Viruses","volume":"8","author":"Lanier","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2006.03.002","article-title":"Surface NK Receptors and Their Ligands on Tumor Cells","volume":"18","author":"Moretta","year":"2006","journal-title":"Semin Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03231-1","article-title":"Natural Cytotoxic Activity of Peripheral-Blood Lymphocytes and Cancer Incidence: An 11-Year Follow-Up Study of a General Population","volume":"356","author":"Imai","year":"2000","journal-title":"Lancet Lond Engl"},{"key":"B5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrc.2015.5","article-title":"NK Cells and Cancer: You Can Teach Innate Cells New Tricks","volume":"16","author":"Morvan","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nature06309","article-title":"Adaptive Immunity Maintains Occult Cancer in an Equilibrium State","volume":"450","author":"Koebel","year":"2007","journal-title":"Nature"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.25.022106.141609","article-title":"Immunosuppressive Strategies That Are Mediated by Tumor Cells","volume":"25","author":"Rabinovich","year":"2007","journal-title":"Annu Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201344272","article-title":"Effect of Tumor Cells and Tumor Microenvironment on NK-Cell Function","volume":"44","author":"Vitale","year":"2014","journal-title":"Eur J Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-1965","article-title":"Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity","volume":"76","author":"Pasero","year":"2016","journal-title":"Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16354","article-title":"Negative Regulation of Tumor-Infiltrating NK Cell in Clear Cell Renal Cell Carcinoma Patients Through the Exosomal Pathway","volume":"8","author":"Xia","year":"2017","journal-title":"Oncotarget"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00496","article-title":"Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients","volume":"10","author":"Lim","year":"2019","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.681615","article-title":"Circulating and Tumor-Infiltrating NK Cells From Clear Cell Renal Cell Carcinoma Patients Exhibit a Predominantly Inhibitory Phenotype Characterized by Overexpression of CD85j, CD45, CD48 and PD-1","volume":"12","author":"Ziblat","year":"2021","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1158\/2159-8290.CD-20-0655","article-title":"Tumor-Infiltrating Natural Killer Cells","volume":"11","author":"C\u00f3zar","year":"2021","journal-title":"Cancer Discov"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202448","article-title":"The Depletion of NK Cells Prevents T Cell Exhaustion to Efficiently Control Disseminating Virus Infection","volume":"190","author":"Cook","year":"2013","journal-title":"J Immunol Baltim Md 1950"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.09.013","article-title":"TRAIL+ NK Cells Control CD4+ T Cell Responses During Chronic Viral Infection to Limit Autoimmunity","volume":"41","author":"Schuster","year":"2014","journal-title":"Immunity"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1118834109","article-title":"Natural Killer Cell Activation Enhances Immune Pathology and Promotes Chronic Infection by Limiting CD8+ T-Cell Immunity","volume":"109","author":"Lang","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI41264","article-title":"Absence of Mouse 2B4 Promotes NK Cell-Mediated Killing of Activated CD8+ T Cells, Leading to Prolonged Viral Persistence and Altered Pathogenesis","volume":"120","author":"Waggoner","year":"2010","journal-title":"J Clin Invest"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-120089","article-title":"Natural Killer Cells Recruited Into Lymph Nodes Inhibit Alloreactive T-Cell Activation Through Perforin-Mediated Killing of Donor Allogeneic Dendritic Cells","volume":"112","author":"Laffont","year":"2008","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/en.2012-1247","article-title":"Immunoregulatory Natural Killer Cells Suppress Autoimmunity by Down-Regulating Antigen-Specific CD8+ T Cells in Mice","volume":"153","author":"Ehlers","year":"2012","journal-title":"Endocrinology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.7.3572","article-title":"Activated, But Not Resting, T Cells Can Be Recognized and Killed by Syngeneic NK Cells","volume":"170","author":"Rabinovich","year":"2003","journal-title":"J\u00a0Immunol Baltim Md 1950"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-052720","article-title":"Antigen-Activated Human T Lymphocytes Express Cell-Surface NKG2D Ligands via an ATM\/ATR-Dependent Mechanism and Become Susceptible to Autologous NK- Cell Lysis","volume":"110","author":"Cerboni","year":"2007","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1004122","article-title":"Cutting Edge: CD8+ T Cell Priming in the Absence of NK Cells Leads to Enhanced Memory Responses","volume":"186","author":"Soderquest","year":"2011","journal-title":"J Immunol Baltim Md 1950"},{"key":"B23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1084\/jem.20121172","article-title":"Up-Regulation of a Death Receptor Renders Antiviral T Cells Susceptible to NK Cell-Mediated Deletion","volume":"210","author":"Peppa","year":"2013","journal-title":"J Exp Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.immuni.2007.03.017","article-title":"Regulation of Activated CD4+ T Cells by NK Cells via the Qa-1-NKG2A Inhibitory Pathway","volume":"26","author":"Lu","year":"2007","journal-title":"Immunity"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nature10624","article-title":"Natural Killer Cells Act as Rheostats Modulating Antiviral T Cells","volume":"481","author":"Waggoner","year":"2011","journal-title":"Nature"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20091193","article-title":"Innate Immunity Defines the Capacity of Antiviral T Cells to Limit Persistent Infection","volume":"207","author":"Andrews","year":"2010","journal-title":"J Exp Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.1.123","article-title":"NK Cell TRAIL Eliminates Immature Dendritic Cells In Vivo and Limits Dendritic Cell Vaccination Efficacy","volume":"172","author":"Hayakawa","year":"2004","journal-title":"J Immunol Baltim Md 1950"},{"key":"B28","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/ar4232","article-title":"Natural Killer Cells in Human Autoimmune Disorders","volume":"15","author":"Fogel","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.3MR0820-685R","article-title":"Regulatory Functions of NK Cells During Infections and Cancer","volume":"109","author":"Zwirner","year":"2021","journal-title":"J Leukoc Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1502291","article-title":"NK Cells Restrain Spontaneous Antitumor CD8+ T Cell Priming Through PD-1\/PD-L1 Interactions With Dendritic Cells","volume":"197","author":"Iraolagoitia","year":"2016","journal-title":"J Immunol Baltim Md 1950"},{"key":"B31","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and Its Ligands in Tolerance and Immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.7.1027","article-title":"Engagement of the PD-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation","volume":"192","author":"Freeman","year":"2000","journal-title":"J Exp Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032414-112049","article-title":"Coinhibitory Pathways in Immunotherapy for Cancer","volume":"34","author":"Baumeister","year":"2016","journal-title":"Annu Rev Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0316-z","article-title":"Development of PD-1 and PD-L1 Inhibitors as a Form of Cancer Immunotherapy: A Comprehensive Review of Registration Trials and Future Considerations","volume":"6","author":"Gong","year":"2018","journal-title":"J Immunother Cancer"},{"key":"B35","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nri3790","article-title":"Clinical Blockade of PD1 and LAG3\u2013potential Mechanisms of Action","volume":"15","author":"Nguyen","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14572","article-title":"Tumour and Host Cell PD-L1 Is Required to Mediate Suppression of Anti-Tumour Immunity in Mice","volume":"8","author":"Lau","year":"2017","journal-title":"Nat Commun"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0391","article-title":"Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape","volume":"5","author":"Noguchi","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1172\/JCI96061","article-title":"PD-L1 on Host Cells Is Essential for PD-L1 Blockade\u2013Mediated Tumor Regression","volume":"128","author":"Tang","year":"2018","journal-title":"J\u00a0Clin Invest"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1172\/JCI96113","article-title":"Host Expression of PD-L1 Determines Efficacy of PD-L1 Pathway Blockade-Mediated Tumor Regression","volume":"128","author":"Lin","year":"2018","journal-title":"J Clin Invest"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-019-0211-5","article-title":"The Cancer Genome Atlas of Renal Cell Carcinoma: Findings and Clinical Implications","volume":"16","author":"Linehan","year":"2019","journal-title":"Nat Rev Urol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: A Web Server for Cancer and Normal Gene Expression Profiling and Interactive Analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","article-title":"NK Cells Stimulate Recruitment of Cdc1 Into the Tumor Microenvironment Promoting Cancer Immune Control","volume":"172","author":"B\u00f6ttcher","year":"2018","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1172\/JCI40645","article-title":"Comprehensive Assessment of Chemokine Expression Profiles by Flow Cytometry","volume":"120","author":"Eberlein","year":"2010","journal-title":"J Clin Invest"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-18-0500","article-title":"A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients","volume":"7","author":"Cursons","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0272-z","article-title":"The Cancer-Natural Killer Cell Immunity Cycle","volume":"20","author":"Huntington","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11321","article-title":"Renal Cell Carcinoma-Infiltrating Natural Killer Cells Express Differential Repertoires of Activating and Inhibitory Receptors and Are Inhibited by Specific HLA Class I Allotypes","volume":"106","author":"Schleypen","year":"2003","journal-title":"Int J Cancer"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-018-0488-3","article-title":"Prognostic and Clinicopathological Significance of PD-L1 in Patients With Renal Cell Carcinoma: A Meta-Analysis Based on 1863 Individuals","volume":"18","author":"Wang","year":"2018","journal-title":"Clin Exp Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/cas.14019","article-title":"Clinical Significance of Programmed Death-1 and Programmed Death-Ligand 1 Expression in the Tumor Microenvironment of Clear Cell Renal Cell Carcinoma","volume":"110","author":"Mikami","year":"2019","journal-title":"Cancer Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-3259","article-title":"PD-L1\/B7H-1 Inhibits the Effector Phase of Tumor Rejection by T Cell Receptor (TCR) Transgenic CD8+ T Cells","volume":"64","author":"Blank","year":"2004","journal-title":"Cancer Res"},{"key":"B51","article-title":"Interleukin-18, a Proinflammatory Cytokine","volume":"11","author":"Dinarello","year":"2000","journal-title":"Eur Cytokine Netw"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-006-9013-3","article-title":"Clinical and Experimental Approaches to the Pathophysiology of Interleukin-18 in Cancer Progression","volume":"25","author":"Vidal-Vanaclocha","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70582-X","article-title":"Cytokine Patterns in Patients With Cancer: A Systematic Review","volume":"14","author":"Lippitz","year":"2013","journal-title":"Lancet Oncol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-006-9000-8","article-title":"The Paradox of Pro-Inflammatory Cytokines in Cancer","volume":"25","author":"Dinarello","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e1294299","DOI":"10.1080\/2162402X.2017.1294299","article-title":"PD-L1 Expression on Malignant Cells Is No Prerequisite for Checkpoint Therapy","volume":"6","author":"Kleinovink","year":"2017","journal-title":"Oncoimmunology"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-1259","article-title":"The Mechanism of Anti-PD-L1 Antibody Efficacy Against PD-L1-Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic Effector","volume":"9","author":"Dong","year":"2019","journal-title":"Cancer Discov"},{"key":"B57","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jaci.2016.04.025","article-title":"Identification of a Subset of Human Natural Killer Cells Expressing High Levels of Programmed Death 1: A Phenotypic and Functional Characterization","volume":"139","author":"Pesce","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1172\/JCI128895","article-title":"CD73 Immune Checkpoint Defines Regulatory NK-Cells Within the Tumor Microenvironment","volume":"130","author":"Neo","year":"2019","journal-title":"J Clin Invest"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0285-7","article-title":"The Immune Contexture and Immunoscore in Cancer Prognosis and Therapeutic Efficacy","volume":"20","author":"Bruni","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B60","article-title":"Proliferative Activity of Intratumoral CD8(+) T-Lymphocytes as a Prognostic Factor in Human Renal Cell Carcinoma: Clinicopathologic Demonstration of Antitumor Immunity","volume":"61","author":"Nakano","year":"2001","journal-title":"Cancer Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.745939\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T06:30:25Z","timestamp":1632119425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.745939\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,20]]},"references-count":60,"alternative-id":["10.3389\/fimmu.2021.745939"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.745939","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,20]]},"article-number":"745939"}}